Vaccine Contract Manufacturing Market Report 2022-2027, Industry Trends, Size, Share, Expansion Plans, Demand, Business Challenges, Opportunities and Major Key Players like Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cobra Biologics L

According to the latest report by IMARC Group, titled "𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟐-𝟐𝟎𝟐𝟕", the global vaccine contract manufacturing market size reached US$ 2.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2027, exhibiting a growth rate (CAGR) of 10.12% during 2022-2027.

Vaccine Contract Manufacturing Market Overview:

Vaccine contract manufacturing refers to the process of outsourcing large-scale production of vaccines to contract manufacturing organizations (CMOs). Pre-formulation work, method development, formulation development, pre-clinical activities, stability studies, registration batches, and commercial manufacturing are some of the services rendered by the organizations. Currently, reduced development costs and complex production protocols are escalating the demand for vaccine contract manufacturing activities.

Vaccine Contract Manufacturing Market: Current Trends & Future Predictions

The global market is primarily driven by the elevating consumer awareness towards vaccines to provide protection from severe illnesses and infectious diseases. Additionally, the increasing need for improving human and veterinary health, along with escalating demand for immunization programs and inoculations is also propelling the market growth. Moreover, the lack of skilled labor and equipment for vaccine production in low-resource nations is contributing to the market growth. Additionally, several technological advancements, like the advent of expression systems, such as the EB66 and GPEx, and cell culture media platforms, are further augmenting the market growth. Besides this, the sudden outbreak of COVID-19 cases has encouraged the vaccine developers to sign outsourcing agreements with CMOs to ramp up the overall production, which will create a positive outlook for market growth in the coming years.

Request to Get the Sample Report: https://www.imarcgroup.com/vaccine-contract-manufacturing-market/requestsample

Vaccine Contract Manufacturing Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:                               

The competitive landscape of the global vaccine contract manufacturing market has been studied in the report with the detailed profiles of the key players operating in the market.

Vaccine Contract Manufacturing Market Key Players:

• Ajinomoto Co. Inc. (OTCMKTS: AJINY)
• Albany Molecular Research Inc
• Catalent Inc (NYSE: CTLT)
• Cobra Biologics Limited (Charles River Laboratories International Inc.)
• Cytovance Biologics Inc. (Hepalink USA Inc.)
• Fujifilm Holdings Corporation (OTCMKTS: FUJIY)
• ICON plc (NASDAQ: ICLR)
• IDT Biologika GmbH
• Lonza Group AG
• Merck KGaA
• Pharmaceutical Product Development LLC
• PRA Health Sciences Inc.

You can buy this report directly (Exclusive offer on this report): https://www.imarcgroup.com/checkout?id=3872&method=1

Vaccine Contract Manufacturing Market Segmentation:

The report has segmented the global vaccine contract manufacturing market on the basis of vaccine type, workflow, application and region.

Based on Vaccine Type:

• Attenuated
• Inactivated
• Subunit-based
• Toxoid-based
• DNA-based

Based on Workflow:

• Downstream
• Upstream

Based on Application:

• Human Use
• Veterinary

Geographical Analysis:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-contract-manufacturing-market

Key highlights of the report:               

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Industry Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse More HealthCare Industry Reports by US:

Healthcare Staffing Market Trends: https://www.imarcgroup.com/healthcare-staffing-market

Antifungal Drugs Market: https://www.imarcgroup.com/antifungal-drugs-market

Sleep Apnea Devices Market: https://www.imarcgroup.com/sleep-apnea-devices-market

Cough Syrup Market: https://www.imarcgroup.com/cough-syrup-market

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.